Evolving Cognition of the JAK-STAT Signaling Pathway: Autoimmune Disorders and Cancer

Scientists discuss advancements in the understanding of JAK-STAT–related pathogenic mechanisms; targeted JAK-STAT therapies for various diseases, especially immune disorders, and cancers; newly developed JAK inhibitors; and current challenges and directions in the field.